The leading independent source for information on the issues that shape oncology since 1973. cancerletter.com
The Cancer Letter
Loading...
Adding immunotherapy to radiation improves disease-free survival in localized prostate cancer, phase III trial finds
https://cancerletter.com/clinical-roundup/20260605_9c/
Advocate Health partners with AI startup to connect more cancer patients to clinical trials
https://cancerletter.com/in-brief/20260605_8c/
OpenEvidence integrates @ascocancer.bsky.social guidelines, figures, and flowcharts into specialty oncology model
https://cancerletter.com/in-brief/20260605_8d/
A note for historians: On April 21, 2026, pancreatic cancer finally began to budge.
https://cancerletter.com/clinical/20260605_1/
Teclistamab improves outcomes in relapsed MM, phase III trial finds
https://cancerletter.com/clinical-roundup/20260605_9b/
"By unleashing hope for pancreatic cancer, we can attest that there is hope for all cancers," Rathmell writes.
https://cancerletter.com/trials-and-tribulations/20260605_2/
On June 3, Johnson brought together a hearing that addressed two subjects: “Plausible Mechanisms of COVID-19 Injections Causing Cancer and Attacks on Scientific Publications and Research.”
https://cancerletter.com/the-cancer-letter/20260605_4/
Advocates for science warn that the vision of the OMB rule replaces scientific merit with political loyalty tests, directly threatening independent science and delaying life-saving medical breakthroughs.
https://cancerletter.com/the-cancer-letter/20260605_3/
"One of the greatest challenges in cancer immunotherapy is finding the rare immune cells, called tumor-reactive T cells, whose job it is to recognize and eliminate tumor cells." - Johns Hopkins Kimmel Sidney Kimmel Comprehensive Cancer Center.
https://cancerletter.com/sponsored-article/20260605_6/
“The National Cancer Institute has concluded—quote—there is no evidence that COVID-19 vaccines cause cancer, lead to recurrence, or lead to disease progression,” said Sen. Richard Blumenthal (D-CT).
https://cancerletter.com/the-cancer-letter/20260605_4/
If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs. To access this subscriber-only content please log in […]
cancerletter.com
The Cancer Letter
The Cancer Letter
The Cancer Letter
The Cancer Letter
The Cancer Letter
The Cancer Letter
The Cancer Letter
The Cancer Letter
The Cancer Letter
Adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival for patients with intermediate- or high-risk localized prostate cancer, according to the results of a multicenter clinical trial led by researchers at the Johns Hopkins University School of Medicine, Johns Hopkins Kimmel Cancer Center, Department of Radiation Oncology […]
Advocate Health and Lind, an AI-powered clinical reserch platform, are partnering to help connect more cancer patients to clinical trials. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe
OpenEvidence announced an integration of ASCO Guidelines, figures, and flowcharts into the OpenEvidence model. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe
The White House Office of Management and Budget has released a 412-page proposal that inserts political appointees into all stages of reviewing and awarding of federal research grants. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all […]
A note for historians: On April 21, 2026, pancreatic cancer finally began to budge. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe
cancerletter.com
Dear Colleagues, Those of us who have devoted our careers to treating recalcitrant cancers know the heartbreak of walking alongside an individual facing an advanced diagnosis. We not only shoulder the clinical responsibility, but also the emotional weight that accompanies every step of that journey as each patient’s story becomes connected to our own. We […]
An international phase III study showed that patients with relapsed multiple myeloma treated with teclistamab lived longer and remained in remission significantly longer than patients receiving standard therapies. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all […]
One of the greatest challenges in cancer immunotherapy is finding the rare immune cells, called tumor-reactive T cells, whose job it is to recognize and eliminate tumor cells. The immune cells collected from a tumor are specific for other targets the patient may have encountered in the past—viruses like flu, COVID, or other pathogens unrelated […]
cancerletter.com
If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs. To access this subscriber-only content please log in […]
